NIKE, Inc.
NIKE, Inc. (NKE) Financial Performance & Income Statement Overview
Analyze NIKE, Inc. (NKE) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
NIKE, Inc. (NKE) Income Statement & Financial Overview
Access detailed annual and quarterly income data for NIKE, Inc. NKE financial performance.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $11.27B | $12.35B | $11.59B | $12.61B |
| Cost of Revenue | $6.59B | $6.96B | $6.33B | $6.97B |
| Gross Profit | $4.67B | $5.39B | $5.26B | $5.63B |
| Gross Profit Ratio | $0.41 | $0.44 | $0.45 | $0.45 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.89B | $4.005B | $4.05B | $4.05B |
| Operating Expenses | $3.89B | $4.005B | $4.05B | $3.96B |
| Total Costs & Expenses | $10.48B | $10.97B | $10.38B | $10.93B |
| Interest Income | $0.00 | $0.00 | $0.00 | $53.00M |
| Interest Expense | -$18.00M | -$67.00M | $0.00 | $0.00 |
| Depreciation & Amortization | -$368.00M | $184.00M | $184.00M | $204.00M |
| EBITDA | $458.00M | $1.17B | $1.39B | $1.75B |
| EBITDA Ratio | $0.04 | $0.09 | $0.12 | $0.14 |
| Operating Income | $788.00M | $1.38B | $1.21B | $1.58B |
| Operating Income Ratio | $0.07 | $0.11 | $0.10 | $0.13 |
| Other Income/Expenses (Net) | $56.00M | $32.00M | $98.00M | $235.00M |
| Income Before Tax | $844.00M | $1.42B | $1.31B | $1.73B |
| Income Before Tax Ratio | $0.07 | $0.11 | $0.11 | $0.14 |
| Income Tax Expense | $50.00M | $253.00M | $256.00M | $226.00M |
| Net Income | $794.00M | $1.16B | $1.05B | $1.50B |
| Net Income Ratio | $0.07 | $0.09 | $0.09 | $0.12 |
| EPS | $0.54 | $0.78 | $0.70 | $0.99 |
| Diluted EPS | $0.54 | $0.78 | $0.70 | $0.99 |
| Weighted Avg Shares Outstanding | $1.49B | $1.49B | $1.50B | $1.52B |
| Weighted Avg Shares Outstanding (Diluted) | $1.49B | $1.49B | $1.50B | $1.52B |
Over the past four quarters, NIKE, Inc. demonstrated steady revenue growth, increasing from $12.61B in Q4 2024 to $11.27B in Q3 2025. Operating income reached $788.00M in Q3 2025, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $458.00M, reflecting operational efficiency. Net income dropped to $794.00M, with EPS at $0.54. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan